Lilly plans IPO for Elanco animal-health unit
The Indianapolis-based pharmaceutical company said the division’s headquarters would remain in Greenfield after the spinoff and that no job cuts are planned.
The Indianapolis-based pharmaceutical company said the division’s headquarters would remain in Greenfield after the spinoff and that no job cuts are planned.
Forty years after starting an ad agency bearing his name, Tom Hirons is letting go of the steering wheel.
Indianapolis Power & Light has agreed not to raise the fixed monthly rate it charges most of its residential customers, under a rate-case settlement it reached with the Indiana Office of Utility Consumer Counselor and other stakeholders.
As the organization’s leaders plan for the next two decades, they’re targeting the 3.3 miles of the White River that runs through their property for new experiences and attractions.
Dr. Dan Skovronsky needs to deliver on the drugmaker’s audacious goal of launching 20 new medicines by 2023.
While the ultimate outcome remains far from certain, the study is a bright spot—if a tenuous one—in the search for a treatment for Alzheimer’s, where more than 100 experimental drugs have failed.
The Lilly Endowment approved 1,062 grants in 2017 for a total of $537.8 million to 788 grantees.
The pharmaceutical company said the 130,000-square-foot building will allow scientists to collaborate better on research for small molecules and synthetic peptides.
The tension between a desire for investment and an inherent distrust of it is occurring across disadvantaged Indianapolis neighborhoods.
Steel Dynamics plans to upgrade its northeast Mississippi steel mill and add 45 jobs at the plant.
Leaders of what’s known as Stadium Village on downtown’s southern edge have been waiting patiently for the area to pop; now, there’s finally enough activity to justify their hopes.
Ascend Indiana, an initiative aimed at closing what local corporate and education leaders say is a stubborn talent gap, is ramping up its operations.
“We’ve just really grown up and kind of grown into what we are today, and it’s been a really neat story,” says Allegion Senior Vice President Tracy Kemp.
Joe Hogsett has written two letters in support of alternative approaches. Though the letters are welcome, we call on him to become the face of the Rethink 65/70 Coalition.
The region got a boost from being home to pharmaceutical giant Eli Lilly and Co., along with numerous contract research organizations, suppliers and testers.
Concordance Health Solutions’ Smart Med Reminder system reminds patients to take their meds and alerts caregivers or providers when an intervention is needed.
U.S. Health and Human Services Secretary Alex Azar told lawmakers that it may be time to eliminate the complex system of rebates that drug companies and pharmacy-benefit managers use to negotiate and set prices.
An independent data-monitoring committee found that the medicine, lanabecestat, was unlikely to meet the goals of the studies, one for early Alzheimer’s and the other for mild dementia related to the disease.
The seventh recipient of the prize has been credited with protecting hundreds of species and millions of acres of critical habitat around the world. He will receive $250,000.
Concordance Health Solutions is launching its product, called Smart Med Reminder, to help address the national epidemic of patients who forget to take their medications, a problem that costs the U.S. health care system nearly $300 billion a year.